August 2018 FDA Recall Drug by Remedyrepack Inc.
D-1146-2018 - CGMP Deviations

This Class II drug recall was voluntarily initiated by Remedyrepack Inc. on August 20, 2018 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in South Carolina and the recall is currently terminated.

Recall Number: D-1146-2018

Reason for Recall
CGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.
Initiated
08-20-2018
Reported
09-05-2018
Quantity
3 bottles of 90 tablets (270 tablets overall)

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Amlodipine/Valsartan/HCTZ 10mg/320mg/25mg Tablet, Rx Only (HDPE 90cc Bottles in cardboard trays) MFG Torrent Pharma LTD, Indrad, India 38272, NDC #70518-1220-0

Batch or Lot Expiration Information

Lot# 70518-1220-0
Lot# : B0476653-080218; Exp. Date: 08/2019